Diagnosing and Managing Uveitis Associated with Immune Checkpoint Inhibitors: A Review

This review aims to provide an understanding of the diagnostic and therapeutic challenges of uveitis associated with immune checkpoint inhibitors (ICI). In the wake of these molecules being increasingly employed as a treatment against different cancers, cases of uveitis post-ICI therapy have also be...

Full description

Bibliographic Details
Main Authors: Huixin Zhang, Lysa Houadj, Kevin Y. Wu, Simon D. Tran
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/14/3/336
_version_ 1797318841448005632
author Huixin Zhang
Lysa Houadj
Kevin Y. Wu
Simon D. Tran
author_facet Huixin Zhang
Lysa Houadj
Kevin Y. Wu
Simon D. Tran
author_sort Huixin Zhang
collection DOAJ
description This review aims to provide an understanding of the diagnostic and therapeutic challenges of uveitis associated with immune checkpoint inhibitors (ICI). In the wake of these molecules being increasingly employed as a treatment against different cancers, cases of uveitis post-ICI therapy have also been increasingly reported in the literature, warranting an extensive exploration of the clinical presentations, risk factors, and pathophysiological mechanisms of ICI-induced uveitis. This review further provides an understanding of the association between ICIs and uveitis, and assesses the efficacy of current diagnostic tools, underscoring the need for advanced techniques to enable early detection and accurate assessment. Further, it investigates the therapeutic strategies for ICI-related uveitis, weighing the benefits and limitations of existing treatment regimens, and discussing current challenges and emerging therapies in the context of their potential efficacy and side effects. Through an overview of the short-term and long-term outcomes, this article suggests recommendations and emphasizes the importance of multidisciplinary collaboration between ophthalmologists and oncologists. Finally, the review highlights promising avenues for future research and development in the field, potentially informing transformative approaches in the ocular assessment of patients under immunotherapy and the management of uveitis following ICI therapy.
first_indexed 2024-03-08T03:58:16Z
format Article
id doaj.art-0810880d3a444f77b9aa3e63b3360f0e
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-08T03:58:16Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-0810880d3a444f77b9aa3e63b3360f0e2024-02-09T15:10:16ZengMDPI AGDiagnostics2075-44182024-02-0114333610.3390/diagnostics14030336Diagnosing and Managing Uveitis Associated with Immune Checkpoint Inhibitors: A ReviewHuixin Zhang0Lysa Houadj1Kevin Y. Wu2Simon D. Tran3Faculty of Medicine, Laval University, Quebec, QC G1V 0A6, CanadaFaculty of Medicine, University of Sherbrooke, Sherbrooke, QC J1G 2E8, CanadaDepartment of Surgery, Division of Ophthalmology, University of Sherbrooke, Sherbrooke, QC J1G 2E8, CanadaFaculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, QC H3A 1G1, CanadaThis review aims to provide an understanding of the diagnostic and therapeutic challenges of uveitis associated with immune checkpoint inhibitors (ICI). In the wake of these molecules being increasingly employed as a treatment against different cancers, cases of uveitis post-ICI therapy have also been increasingly reported in the literature, warranting an extensive exploration of the clinical presentations, risk factors, and pathophysiological mechanisms of ICI-induced uveitis. This review further provides an understanding of the association between ICIs and uveitis, and assesses the efficacy of current diagnostic tools, underscoring the need for advanced techniques to enable early detection and accurate assessment. Further, it investigates the therapeutic strategies for ICI-related uveitis, weighing the benefits and limitations of existing treatment regimens, and discussing current challenges and emerging therapies in the context of their potential efficacy and side effects. Through an overview of the short-term and long-term outcomes, this article suggests recommendations and emphasizes the importance of multidisciplinary collaboration between ophthalmologists and oncologists. Finally, the review highlights promising avenues for future research and development in the field, potentially informing transformative approaches in the ocular assessment of patients under immunotherapy and the management of uveitis following ICI therapy.https://www.mdpi.com/2075-4418/14/3/336immune checkpoint inhibitoruveitisVogt-Koyanagi-Haradabirdshot-like uveitisimmunotherapyCTLA-4 inhibitors
spellingShingle Huixin Zhang
Lysa Houadj
Kevin Y. Wu
Simon D. Tran
Diagnosing and Managing Uveitis Associated with Immune Checkpoint Inhibitors: A Review
Diagnostics
immune checkpoint inhibitor
uveitis
Vogt-Koyanagi-Harada
birdshot-like uveitis
immunotherapy
CTLA-4 inhibitors
title Diagnosing and Managing Uveitis Associated with Immune Checkpoint Inhibitors: A Review
title_full Diagnosing and Managing Uveitis Associated with Immune Checkpoint Inhibitors: A Review
title_fullStr Diagnosing and Managing Uveitis Associated with Immune Checkpoint Inhibitors: A Review
title_full_unstemmed Diagnosing and Managing Uveitis Associated with Immune Checkpoint Inhibitors: A Review
title_short Diagnosing and Managing Uveitis Associated with Immune Checkpoint Inhibitors: A Review
title_sort diagnosing and managing uveitis associated with immune checkpoint inhibitors a review
topic immune checkpoint inhibitor
uveitis
Vogt-Koyanagi-Harada
birdshot-like uveitis
immunotherapy
CTLA-4 inhibitors
url https://www.mdpi.com/2075-4418/14/3/336
work_keys_str_mv AT huixinzhang diagnosingandmanaginguveitisassociatedwithimmunecheckpointinhibitorsareview
AT lysahouadj diagnosingandmanaginguveitisassociatedwithimmunecheckpointinhibitorsareview
AT kevinywu diagnosingandmanaginguveitisassociatedwithimmunecheckpointinhibitorsareview
AT simondtran diagnosingandmanaginguveitisassociatedwithimmunecheckpointinhibitorsareview